Exploration ofexercise-related genetic polymorphisms, particularly in the peroxisomeproliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), andtheir impact on AF risk may offer novel insights into patient-specific responsesto exercise and further personalize therapeutic strategies [75]. Here, PPARGC1A is linked to atrial fibrillation.